PHGE
BiomX Inc.
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“substantial doubt about our ability to continue as a going concern”View the 10-Q filed May 20, 2026
Company with tickers: PHGE
CIK
1739174
CUSIP
09090D509
Shares Outstanding
11,160,153
Website
https://www.biomx.com
13F Activity (30d)
3 filings
3 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,375,022 |
| Dr. Merav Bassan | — | $642,330 |
| Marina Wolfson | CFO | $553,454 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,078,592 |
| Dr. Merav Bassan | — | $532,982 |
| Marina Wolfson | CFO | $351,552 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,118,541 |
| Dr. Merav Bassan | — | $590,931 |
| Marina Wolfson | CFO | $428,256 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,041,542 |
| Dr. Merav Bassan | — | $562,948 |
| Marina Wolfson | CFO | $396,243 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,334,997 |
| Dr. Merav Bassan | — | $689,610 |
| Assaf Oron | — | $496,213 |
| Marina Wolfson | CFO | $444,377 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $1,101,817 |
| Dr. Merav Bassan | — | $730,837 |
| Dr. Sailaja Puttagunta | — | $713,859 |
| Assaf Oron | — | $443,882 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $936,565 |
| Dr. Sailaja Puttagunta | — | $726,485 |
| Assaf Oron | — | $455,692 |
| Dr. Merav Bassan | — | $354,810 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | CEO | $604,553 |
| Assaf Oron | — | $322,799 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Roy Rousso | Chief Business Officer | Appointed | 2026-05-28 |